Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Effect of a single mutation in neuraminidase on the properties of Influenza B virus isolates.

Katinger D, Romanova J, Ferko B, Fekete H, Egorov A.

Arch Virol. 2004 Jan;149(1):173-81. Epub 2003 Sep 22.

PMID:
14689282
[PubMed - indexed for MEDLINE]
2.

Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations.

Jackson D, Barclay W, Z├╝rcher T.

J Antimicrob Chemother. 2005 Feb;55(2):162-9. Epub 2005 Jan 21.

PMID:
15665027
[PubMed - indexed for MEDLINE]
Free Article
3.

Effects of site-specific mutation on structure and activity of influenza virus B/Lee/40 neuraminidase.

Wei X, Els MC, Webster RG, Air GM.

Virology. 1987 Feb;156(2):253-8.

PMID:
3811237
[PubMed - indexed for MEDLINE]
4.

Influenza type B neuraminidase can replace the function of type A neuraminidase.

Ghate AA, Air GM.

Virology. 1999 Nov 25;264(2):265-77.

PMID:
10562491
[PubMed - indexed for MEDLINE]
Free Article
5.

A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding.

Baum EZ, Wagaman PC, Ly L, Turchi I, Le J, Bucher D, Bush K.

Antiviral Res. 2003 Jun;59(1):13-22.

PMID:
12834856
[PubMed - indexed for MEDLINE]
6.

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.

Gubareva LV.

Virus Res. 2004 Jul;103(1-2):199-203.

PMID:
15163510
[PubMed - indexed for MEDLINE]
7.

Approach to the involvement of influenza B neuraminidase in the cleavage of HA by host cell protease using low pH-induced cell fusion reaction.

Yamamoto-Goshima F, Maeno K.

Microbiol Immunol. 1994;38(10):819-22.

PMID:
7869962
[PubMed - indexed for MEDLINE]
8.

Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids.

Jariwalla RJ, Roomi MW, Gangapurkar B, Kalinovsky T, Niedzwiecki A, Rath M.

Biofactors. 2007;31(1):1-15.

PMID:
18806304
[PubMed - indexed for MEDLINE]
9.

Comparative study of influenza virus replication in Vero and MDCK cell lines.

Youil R, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Kiseleva I, Shaw AR, DiStefano D.

J Virol Methods. 2004 Sep 1;120(1):23-31.

PMID:
15234806
[PubMed - indexed for MEDLINE]
10.

Isolation and classification of temperature-sensitive mutants of influenza B virus.

Yamamoto-Goshima F, Aoki H, Takada T, Toda S, Yoshii S, Maeno K.

Microbiol Immunol. 1994;38(9):757-61.

PMID:
7854217
[PubMed - indexed for MEDLINE]
11.

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.

Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, Lina B, Morfin F, Ferraris O.

J Clin Virol. 2008 Jan;41(1):25-8. Epub 2007 Dec 4.

PMID:
18055253
[PubMed - indexed for MEDLINE]
12.

Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.

Zhirnov OP, Vorobjeva IV, Saphonova OA, Poyarkov SV, Ovcharenko AV, Anhlan D, Malyshev NA.

J Clin Virol. 2009 Aug;45(4):322-33. doi: 10.1016/j.jcv.2009.05.030.

PMID:
19546028
[PubMed - indexed for MEDLINE]
13.

Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus.

Yano T, Nobusawa E, Nagy A, Nakajima S, Nakajima K.

Microbiol Immunol. 2008 Apr;52(4):216-23. doi: 10.1111/j.1348-0421.2008.00034.x.

PMID:
18426396
[PubMed - indexed for MEDLINE]
14.

Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substrates.

Katinger D, Mochalova L, Chinarev A, Bovin N, Romanova J.

Arch Virol. 2004 Nov;149(11):2131-40. Epub 2004 Jun 30.

PMID:
15503202
[PubMed - indexed for MEDLINE]
15.

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG.

J Infect Dis. 2006 Mar 15;193(6):760-4. Epub 2006 Feb 13. Review.

PMID:
16479508
[PubMed - indexed for MEDLINE]
Free Article
16.

Sequence and crystallization of influenza virus B/Beijing/1/87 neuraminidase.

Burmeister WP, Daniels RS, Dayan S, Gagnon J, Cusack S, Ruigrok RW.

Virology. 1991 Jan;180(1):266-72.

PMID:
1984652
[PubMed - indexed for MEDLINE]
17.

Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.

Yen HL, Hoffmann E, Taylor G, Scholtissek C, Monto AS, Webster RG, Govorkova EA.

J Virol. 2006 Sep;80(17):8787-95.

PMID:
16912325
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.

Cheam AL, Barr IG, Hampson AW, Mosse J, Hurt AC.

Antiviral Res. 2004 Sep;63(3):177-81.

PMID:
15451185
[PubMed - indexed for MEDLINE]
19.

Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.

Horimoto T, Iwatsuki-Horimoto K, Hatta M, Kawaoka Y.

Microbes Infect. 2004 May;6(6):579-83.

PMID:
15158192
[PubMed - indexed for MEDLINE]
20.

Rescue of a viral gene from VERO cells latently infected with influenza virus B/Lee/40.

Tobita K, Tanaka T, Hayase Y.

Virology. 1997 Sep 15;236(1):130-6.

PMID:
9299625
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk